Crossmark

Imetelstat as a novel therapeutic approach for myelodysplastic syndrome

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.09.2484

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Arain, Ammara Waheed https://orcid.org/0009-0007-2121-199X
Andani, Anushka

Kashif, Aayat https://orcid.org/0009-0007-2678-1633
Waseem, Radeyah
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2024-11-05
More Information

This article is maintained by: Elsevier

Article Title: Imetelstat as a novel therapeutic approach for myelodysplastic syndrome

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.09.2484

Content Type: simple-article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.